MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'fentora'. Sat, 03 Sep 2011 02:38:10 +0100 http://www.medworm.com/index.php?rid=4636662&cid=t_131168_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FlYLOC-LmD10%2F And so another working week soon draws to a close. This is, of course, the signal to dream about weekend plans. Our agenda calls for spending time with the short people and cleaning up around the Pharmalot corporate campus. And you? Will you catch up on some sleep? Read an e-book? Take a walk in the park? Have a good time, whatever you do. And be safe. Meanwhile, here are some tidbits. Catch you soon, everyone… Medical Marijuana Sales Rival Viagra (Time) Cephalon Wins Ruling Over Generic Copy Of Watson’s Fentora (Reuters) Martin Sheen Testifies In Accutane Trial (ABA Journal) Branded Discounts Save Seniors $38M In Two Months (Pharma Times) Prevanar Vaccine To Resume In Japan (Bloomberg News) Pfizer Drugs Shrinks Pancreatic Tumors In Research (Bloomberg News) FDA OKs Merck Shing... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4636662 Fri, 25 Mar 2011 12:10:36 +0100 4636662 http://www.medworm.com/index.php?rid=1531694&cid=t_131168_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F316159558%2F The US Drug Enforcement Agency is getting ready to allow highly addictive meds, including powerful painkillers, to be prescribed online, something that health insurers and large employers have been pushing, the Associated Press reports. Under current government rules, docs are required to write out by hand prescriptions for controlled substances, which include attention-deficit disorder drugs like Shire’s Adderall and painkillers like Cephalon’s Fentora. The concern is that patients are more likely to abuse these treatments, and their prescriptions should be monitored more closely. But the DEA will soon publish a proposal that would allow docs to prescribe such drugs electronically, according to an agency spokeswoman Rogene Waite, while declining to say which specific drug clas... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1531694 Fri, 20 Jun 2008 11:03:20 +0100 1531694 http://www.medworm.com/index.php?rid=1426774&cid=t_131168_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F285330212%2F Do you remember what the Morning Mayor used to say? Every brand new day should be unwrapped like a precious gift. So go ahead, open yours. And after you do so, grab a cup of something refreshing and take a peek at these… Baxter Says Heparin Legal Costs Are Insignificant (The Chicago Tribune) Roche Targets Diabetes To Replace Cancer Sales (Bloomberg News) FDA Panel Rejects Wider Use of Cephalon Drug (Yahoo/Reuters) Teva Seeks Judgment On Nexium Patents (Yahoo/Reuters) (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1426774 Wed, 07 May 2008 11:54:58 +0100 1426774 http://www.medworm.com/index.php?rid=1416439&cid=t_131168_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F282207916%2F The agency is concerned that the powerful Fentora pain drug will be easily abused if made available on a widespread basis. Right now, the Cephalon lozenge is used to treat pain associated with acute pain suffered by cancer patients, but the drugmaker wants FDA approval to sell the narcotic to treat sudden pain in others. Last September, the FDA issued an advisory linking Fentora to four deaths, and Cephalon blamed inappropriate prescribing for such ailments as back pain. The drugmaker, however, denied off-label marketing activities, which came under investigation by the US attorney in Philadelphia, the Connecticut attorney general, and a congressional committee. But next Tuesday, an FDA advisory committee will meet to review Cephalon’s request for wider approval. “We are concer... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1416439 Fri, 02 May 2008 16:32:48 +0100 1416439 http://www.medworm.com/index.php?rid=1072405&cid=t_131168_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F195737938%2Fdrug_warnings_and_withdrawls_f_1.html FiercePharma has compiled a list of the top 10 drugs to have who have had approval either withdrawn or been forced to add stronger warning labels, by the FDA, with respect to their pharmaceutical products.  The list is based on 2006 worldwide sales so ranking does not necessarily include the big new makers.1. Antidepressants - Various companies - "Black" box warning regarding increased risk of suicidal thoughts.2. Epogen/Aranesp - Amgen - "Black" box warning of heart and vascular risk at higher doses3. Zyprexa - Lilly - Warning of weight gain and metabolic problems4. Avandia - Glaxo - "Black" box warning of heart failure and heart attack5. Actos - Takeda - "Black" box warning of heart failure6. Provigil - Cephalon - Waning of Stevens-J... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=1072405 Wed, 05 Dec 2007 20:00:41 +0100 1072405 http://www.medworm.com/index.php?rid=1072406&cid=t_131168_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F195734875%2Ffda_warns_of_potential_side_ef.html September 2007The U.S Food and Drug Administration alerted healthcare professionals and consumers of the possible side effects of Fentora (fentanyl buccal) after reports of deaths and other adverse events.Fentora, an opiod pain medication, is used only for the treatment of breakthrough pain in cancer patients already receiving opiod treatment who have become tolerant to it. Those who have not developed a tolerance for opiods are at risk of suffering the dangerous side effects associated with this drug. All deaths reported were a result of improper selection of patients, dosing, or improper product substitution."FDA is monitoring this issue very closely," said Steven Galson, M.D., M.P.H., director of FDA’s Center for Drug Evaluation and Research. "We are working with th... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=1072406 Wed, 05 Dec 2007 19:00:20 +0100 1072406 http://www.medworm.com/index.php?rid=1068797&cid=t_131168_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F194961311%2F In case you missed it, this has been quite a year for high-profile safety news. And so FiercePharma has compiled a list for the cocktail set, who want to keep track of such things. These are the 10 biggest drugs that were withdrawn or were issued new warnings by the FDA this year. The drugs are ranked by 2006 worldwide sales, which explains why such headline grabbers as Bayer’s Trasylol doesn’t appear - sales were already tanking on bad news. 1. Antidepressants - Various companies 2. Epogen/Aranesp - Amgen 3. Zyprexa - Lilly 4. Avandia - Glaxo 5. Actos - Takeda 6. Provigil - Cephalon 7. Zelnorm - Novartis 8. Byetta - Amylin 9. Xolair - Genentech 10. Fentora - Cephalon Source: FiercePharma Share / E-mail (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1068797 Tue, 04 Dec 2007 14:15:23 +0100 1068797 http://www.medworm.com/index.php?rid=1021393&cid=t_131168_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F183627204%2F As always, Monday mornings are busy. And so while we pursue various strands of information, we thought we would keep you up to date on other matters. Besides, what better way to enjoy a cup of coffee or tea than with something interesting to read? Cephalon Seeks FDA Approval For Expanded Use Of Fentora (bizjournals.com) Medco To Spend $140M On Automated Plant In Indiana (Yahoo/Reuters) AstraZeneca Axes South Africa Packaging Plant (OutsourcingPharma) Finnish Gunman Claimed To Have Used Antidepressants (Helsingin Sanomat) Share / E-mail (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1021393 Mon, 12 Nov 2007 16:05:12 +0100 1021393 http://www.medworm.com/index.php?rid=1015911&cid=t_131168_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F181979143%2F The drugmaker struck a deal with the US Attorney in Philadelphia, and will sign a corporate integrity agreement after agreeing to a misdemeanor violation of the Food, Drug and Cosmetic Act. The probe reportedly focused on whether Cephalon sales reps were improperly marketing its Provigil narcolepsy drug, which docs have prescribed to treat depression and ADHD. The settlement doesn’t come as a surprise. Cephalon has been under a microscope for off-label marketing for awhile. Last February, the FDA sent the drugmaker a warning letter ordering an end to promotional material for Provigil that included claims that the drug could be used to treat fatigue, which isn’t an approved use. Two months ago, Cephalon sent letters to docs this week warning that several deaths have been linked... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1015911 Fri, 09 Nov 2007 03:30:39 +0100 1015911 http://www.medworm.com/index.php?rid=906264&cid=t_131168_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F161618371%2F The agency is cautioning patients and docs about about potentially fatal risks connected with Fentora, a powerful painkiller, because off-label use could result in fatal overdoses. The FDA approved the highly addictive narcotic last year to treat acute pain suffered by cancer patients. Since then, Fentora has been linked to four deaths and Cephalon is blaming inappropriate prescribing for such ailments as back pain. The drugmaker, however, denies off-label marketing activities. But its being investigated by the US attorney in Philadelphia and the Connecticut attorney general (see page 11 of the latest SEC filing), and faces a congressional probe into off-label treatments. FDA stressed that Fentora shouldn’t be used to treat short-term pain such as migraines and shouldn’t be use... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=906264 Wed, 26 Sep 2007 17:35:21 +0100 906264 http://www.medworm.com/index.php?rid=873929&cid=t_131168_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F156847082%2F The drugmaker argues the problem is all about inappropriate prescribing. So Cephalon sent letters to docs this week warning that several deaths have been linked to Fentora, a highly addictive narcotic used to treat acute cancer pain. Here’s the catch - Fentora and its predecessor, Actiq, are approved only for use in cancer patients, but are often prescribed off-label for headaches and back pain. Cephalon has always denied any off-label marketing, but its being investigated by the US attorney in Philadelphia and the Connecticut attorney general (see page 11 of the latest SEC filing), and a congressional probe into off-label treatments. (In the wake of the OxyContin scandal, this shouldn’t come as a surprise). A Cephalon press release wasn’t specific about the number of de... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=873929 Sat, 15 Sep 2007 13:04:48 +0100 873929 http://www.medworm.com/index.php?rid=870397&cid=t_131168_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F09%2F14%2Ffentora-cancer-related-drug-deaths-confirmed-by-cephalon%2F Filed under: Drug, All CancersIt's never a good thing when a drugmaker sends letters to doctors saying that a drug they are prescribing has resulted in confirmed deaths.But that is what Cephalon did this week, as it admitted its cancer drug -- Fentora - has been linked to some patient deaths. Fentora, used to treat acute cancer pain, are sometimes prescribed for other pain-related ailments.Cephalon took issue with the apparent claim that it markets Fentora for uses other than cancer pain, even though some doctors use it "off label" in normal practice.Read | Permalink | Email this | Linking Blogs | Comments (Source: The Cancer Blog) The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=870397 Fri, 14 Sep 2007 04:00:00 +0100 870397 http://www.medworm.com/index.php?rid=728727&cid=t_131168_150_f&fid=35781&url=http%3A%2F%2Fwww.qdinformation.com%2Fqdisblog%2F2007%2F03%2F20%2Frep-waxman-requests-information-from-pharmaceutical%2F Seems Representative Henry Waxman (D, CA) wants to hear from the following companies about the following drugs for the following reasons: Lilly: Zyprexa (bipolar). Inappropriate promotion for off-label use AstraZeneca: Seroquel (schizophrenia). Inappropriate marketing Boston Scientific: drug coated stents. Safety and off-label use Cordis: drug coated stents. Safety and off-label use Cephalon: Actiq (narcotic lollipop) and Fentora (narcotic lozenge). Inappropriate marketing PharmaLive: Rep. Waxman Requests Research and Marketing Information from Pharmaceutical and Medical Device Companies : Here are the letters that were sent. WaxmanLilly.pdf WaxmanAZ.pdf WaxmanBoston.pdf WaxmanCordis.pdf WaxmanCephalon.pdf The longest letter went to Cephalon over their narcotic products . All the letters a... QDIS Blog blogs http://www.medworm.com/rss/comments.php?id=728727 Tue, 20 Mar 2007 15:19:56 +0100 728727